WELL Health Technologies Corp. Stock

Equities

WELL

CA94947L1022

Healthcare Facilities & Services

Market Closed - Toronto S.E. 04:00:00 2024-06-21 pm EDT 5-day change 1st Jan Change
4.25 CAD +3.41% Intraday chart for WELL Health Technologies Corp. +1.19% +10.39%
Sales 2024 * 972M 709M Sales 2025 * 1.07B 781M Capitalization 1.01B 738M
Net income 2024 * 6M 4.38M Net income 2025 * 4M 2.92M EV / Sales 2024 * 1.33 x
Net Debt 2024 * 279M 204M Net Debt 2025 * 264M 193M EV / Sales 2025 * 1.19 x
P/E ratio 2024 *
117 x
P/E ratio 2025 *
-259 x
Employees 1,507
Yield 2024 *
-
Yield 2025 *
-
Free-Float 92.85%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : WELL Health Technologies Corp. - Shareholder/Analyst Call
WELL Health Agrees to Automatic Share Purchase Plan with Broker MT
WELL Health Obtains TSX Approval For Normal Course Issuer Bid MT
Well Health Brief: Announcing Approval of Normal Course Issuer Bid MT
WELL Health Technologies Corp. announces an Equity Buyback for 6,154,501 shares, representing 2.5% of its issued share capital. CI
WELL Health Technologies Corp. authorizes a Buyback Plan. CI
WELL Health Technologies Corp.'s Equity Buyback announced on May 31, 2023, has expired. CI
HEALWELL AI Brief: Says Strategic alliance with WELL Health Technologies Corp. "Continues To Flourish" MT
Transcript : WELL Health Technologies Corp., Q1 2024 Earnings Call, May 08, 2024
WELL Health Technologies Posts Q1 Adjusted Earnings and Revenues Beat; Also Flags 2024 Revenues Beat and Free Cash Flow Improvement MT
Tranche Update on WELL Health Technologies Corp.'s Equity Buyback Plan announced on May 31, 2023. CI
WELL Health Technologies Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Well Health Brief: increasing its guidance range for 2024 annual revenue of between $960-$980 million, while guiding to upper range of its previous Adjusted EBITDA guidance of $125-$130 million MT
Well Health Brief: Says Achieved Net Income of $19.6 million or $0.06 per share and record quarterly revenues of $231.6 Million in Q1-2024 MT
WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024 CI
More news

Latest transcript on WELL Health Technologies Corp.

1 day-2.61%
1 week-2.14%
Current month+9.60%
1 month+7.87%
3 months-3.07%
6 months+8.44%
Current year+6.75%
More quotes
1 week
4.08
Extreme 4.08
4.29
1 month
3.63
Extreme 3.63
4.29
Current year
3.41
Extreme 3.41
4.31
1 year
3.41
Extreme 3.41
4.93
3 years
2.56
Extreme 2.56
8.86
5 years
0.90
Extreme 0.9
9.84
10 years
0.11
Extreme 0.11
9.84
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 10-11-22
Director of Finance/CFO - -
Director of Finance/CFO 59 10-10-31
Members of the board TitleAgeSince
Director/Board Member 50 18-04-29
Director/Board Member 73 16-03-23
Chief Executive Officer 49 10-11-22
More insiders
Date Price Change Volume
24-06-21 4.25 +3.41% 1 288 082
24-06-20 4.11 -2.61% 845,472
24-06-19 4.22 0.00% 311,196
24-06-18 4.22 +0.72% 804,881
24-06-17 4.19 -0.24% 641,202

Delayed Quote Toronto S.E., June 20, 2024 at 04:00 pm EDT

More quotes
WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
4.11 CAD
Average target price
7.446 CAD
Spread / Average Target
+81.18%
Consensus